Hospira has emerged as a bidder for Danone’s medical-nutrition unit, which makes food for the sick, young and elderly, in a deal that could be worth about $5 billion and is the latest in a flurry of tax inversion deals designed to sidestep U.S. taxes,The Wall Street Journal reports.
Midwest healthcare startups reported $777 millionin total investments across 139 companies in the first half of 2014, according to the BioEnterprise Midwest Healthcare Venture Investment Report. The totals are the highest recorded for the region both in dollars of financing and number of companies funded since BioEnterprise began compiling the report in 2005.
Over the past two decades, 3-D printing has grown from a niche technology to a multibillion-dollar industry. The manufacturing process was developed in the 1980s as a way to produce small volumes of scale models but has since expanded to include the manufacturing of medical devices and implants for surgical and clinical use. The process, also known as additive manufacturing, uses computer models to build three-dimensional objects by printing materials like plastic, polymers, metals and powders in layers.
Today AdvaMed announced the Emerging Growth Company Scholarships for 29 Company Presentations, through the generous support of Aon, the National Institutes of Health, PROPEL and RCT Ventures.
AdvaMed 2014 is the leading MedTech Conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking. An event rich in international flavor and featuring a deep, diverse attendee list that includes influential policy-makers, business executives and media, AdvaMed 2014 seeks to advance industry discussion from key perspectives through detailed panel sessions, executive forums and more. It is a “must-attend” event for any MedTech company.
NanoCytomics LLC, a privately held medical technology company developing novel cancer risk-stratification tests for use in primary care physicians’ offices, today announced the appointment of John W. Hart as president. Hart brings to NanoCytomics 35 years of experience in various healthcare sectors, including more than two decades at Baxter International, Allegiance and Cardinal Health.